Literature DB >> 22975571

Successful treatment of fulminant community-acquired Pseudomonas aeruginosa necrotizing pneumonia in a previously healthy young man.

Kei Kunimasa1, Tadashi Ishida, Soichiro Kimura, Maki Tanaka, Yuichi Kouyama, Shigeki Yamashita, Mitsunori Morita, Hiromasa Tachibana, Fumiaki Tokioka, Akihiro Ito, Chisato Sumi, Kazuhiro Tateda.   

Abstract

This report presents a case of fulminant community-acquired Pseudomonas aeruginosa necrotizing pneumonia in a previously healthy young man, including an analysis of the virulence of the P.aeruginosa isolated from the patient. The patient was successfully treated with intensive care and antibiotic treatment. This study analyzed the pathogenicity of the isolated strain both in vivo (using a mouse pneumonia model) and in vitro (using biofilm production), but could not explain how an otherwise healthy young man developed such severe community-acquired P.aeruginosa pneumonia. Although rare in community-acquired pneumonia, P.aeruginosa infection should be considered in patients with severe rapidly progressive pneumonia.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22975571     DOI: 10.2169/internalmedicine.51.7596

Source DB:  PubMed          Journal:  Intern Med        ISSN: 0918-2918            Impact factor:   1.271


  8 in total

1.  Virulent Pseudomonas aeruginosa pneumonia in an immunocompetent adult associated with a home whirlpool bath: A case report.

Authors:  Yasumaro Fujiki; Naoko Mato; Shinya Watanabe; Tomoki Shibano; Ken Tonai; Kento Takahashi; Tatsuya Saito; Akiko Okuyama; Ayako Takigami; Masashi Bando; Takuji Suzuki; Longzhu Cui; Koichi Hagiwara
Journal:  Respir Med Case Rep       Date:  2022-06-02

2.  30-day mortality in UK patients with bacteraemic community-acquired pneumonia.

Authors:  M Melzer; C Welch
Journal:  Infection       Date:  2013-05-24       Impact factor: 3.553

3.  Prevalence and risk factors for bloodstream infection present on hospital admission.

Authors:  Sainfer Aliyu; Bevin Cohen; Jianfang Liu; Elaine Larson
Journal:  J Infect Prev       Date:  2017-07-28

4.  Community-acquired, hospital-acquired, and healthcare-associated pneumonia caused by Pseudomonas aeruginosa.

Authors:  Ayumi Fujii; Masafumi Seki; Masachika Higashiguchi; Isao Tachibana; Atsushi Kumanogoh; Kazunori Tomono
Journal:  Respir Med Case Rep       Date:  2014-03-26

5.  Community-acquired Pseudomonas aeruginosa-pneumonia in a previously healthy man occupationally exposed to metalworking fluids.

Authors:  Fernando Peixoto Ferraz de Campos; Aloísio Felipe-Silva; Ana Claudia Frota Machado de Melo Lopes; Lilian Ferri Passadore; Stella Maria Guida; Angélica Jean Balabakis; João Augusto Dos Santos Martines
Journal:  Autops Case Rep       Date:  2014-09-30

6.  Necrotizing Pseudomonas aeruginosa Community-Acquired Pneumonia: A Case Report and Review of the Literature.

Authors:  Satish Maharaj; Carmen Isache; Karan Seegobin; Simone Chang; Grant Nelson
Journal:  Case Rep Infect Dis       Date:  2017-05-17

7.  Septic shock secondary to an acute necrotizing community-acquired pneumonia with bacteremia due to Pseudomonas aeruginosa.

Authors:  P Riviere; D Patin; E Delaporte; H Mahfoudi; S Lecailtel; F Poher; P Villette; J Duclaux; P Jouault; G Brunin
Journal:  IDCases       Date:  2019-05-16

8.  Virulence Attributes and Host Response Assays for Determining Pathogenic Potential of Pseudomonas Strains Used in Biotechnology.

Authors:  Azam F Tayabali; Gordon Coleman; Kathy C Nguyen
Journal:  PLoS One       Date:  2015-11-30       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.